$CDTX Cidara Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Cidara Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cidara Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Cidara Therapeutics, Inc. for free.
CIK Number: 0001610618
IRS Number: 461537286
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CDTX
Company Address: 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO 92121
Phone number: 858-752-6170
Former name: K2 THERAPEUTICS, INC., date of change: 2014-06-11
Market Capitalization: $167.56M
Prev close: $9.60
Average Daily Volume: 51,160
Days Low: $9.57
Year Low: $8.65
Year High: $15.91
Cidara Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | CDTX | Cidara Therapeutic ... | BURGESS DANIEL D | Director | Option Exercise | A | 1.92 | 17,500 | 33,600 | 17,500 | |
Apr 05 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Sell | S | 2.66 | 1,177 | 3,131 | 7,764 | 8.9 K to 7.8 K (-13.16 %) |
Apr 05 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Grant | A | 0.00 | 2,800 | 0 | 8,941 | 6.1 K to 8.9 K (+45.60 %) |
Apr 05 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Sell | S | 2.06 | 824 | 1,697 | 6,141 | 7 K to 6.1 K (-11.83 %) |
Apr 05 2021 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 700 | 0 | 82,031 | 81.3 K to 82 K (+0.86 %) |
Apr 05 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Grant | A | 0.00 | 10,000 | 0 | 361,878 | 351.9 K to 361.9 K (+2.84 %) |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 2.55 | 130,000 | 331,500 | 130,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.55 | 150,000 | 382,500 | 150,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.55 | 120,000 | 306,000 | 120,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Sandison Taylor | Chief Medical Offic ... | Option Exercise | A | 2.55 | 145,000 | 369,750 | 145,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 2.55 | 130,000 | 331,500 | 130,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Oien Jessica | General Counsel & S ... | Option Exercise | A | 2.55 | 135,000 | 344,250 | 135,000 | |
Mar 19 2021 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.55 | 150,000 | 382,500 | 150,000 |